Navigation auf uzh.ch
Navigation auf uzh.ch
As coordinator of the ImageTDP43 consortium, the Polymenidou group has been awarded a competitive EU Consortium Grant from the 'EU Joint Programme - Neurodegenerative Disease Research (JPND).
The project 'ImageTDP43: Imaging heterogeneous TDP-43 neuropathologies' aims at developing TDP-43 PET ligands that will allow to accurately detect and monitor TDP-43-related neurodegenerative progression in diseases such as amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP).
The ImageTDP43 consortium brings together world-class academic partners from Fondazione Santa Lucia (Italy), Skåne University Hospital (Sweden) and Erasmus Medical Center (Netherlands), as well as industry partner AC Immune (Switzerland).
Please also read AC Immune's press release, which can be found here.
